Mycobacterium haemophilum infection after alemtuzumab treatment

MeSH terms

• Adolescent
• Aged
• Alemtuzumab
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antibodies, Neoplasm / adverse effects*
• Antibodies, Neoplasm / therapeutic use
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Communicable Diseases, Emerging / diagnosis*
• Communicable Diseases, Emerging / etiology
• Communicable Diseases, Emerging / microbiology
• Fatal Outcome
• Female
• Humans
• Immunocompromised Host
• Immunosuppressive Agents / adverse effects*
• Immunosuppressive Agents / therapeutic use
• Leukemia, Lymphoid / drug therapy
• Male
• Mycobacterium Infections / diagnosis*
• Mycobacterium Infections / etiology
• Mycobacterium Infections / microbiology
• Mycobacterium haemophilum*
• Myelodysplastic Syndromes / drug therapy
• Skin Diseases, Bacterial / diagnosis*
• Skin Diseases, Bacterial / etiology
• Skin Diseases, Bacterial / microbiology